Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Operating Expenses: 2019-2024

Historic Operating Expenses for Caribou Biosciences (CRBU) over the last 6 years, with Dec 2024 value amounting to $176.6 million.

  • Caribou Biosciences' Operating Expenses fell 21.52% to $31.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $168.1 million, marking a year-over-year decrease of 4.87%. This contributed to the annual value of $176.6 million for FY2024, which is 17.32% up from last year.
  • Caribou Biosciences' Operating Expenses amounted to $176.6 million in FY2024, which was up 17.32% from $150.5 million recorded in FY2023.
  • In the past 5 years, Caribou Biosciences' Operating Expenses ranged from a high of $176.6 million in FY2024 and a low of $48.5 million during FY2020.
  • For the 3-year period, Caribou Biosciences' Operating Expenses averaged around $149.1 million, with its median value being $150.5 million (2023).
  • Data for Caribou Biosciences' Operating Expenses shows a peak YoY skyrocketed of 57.94% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Caribou Biosciences' Operating Expenses stood at $48.5 million in 2020, then surged by 57.94% to $76.6 million in 2021, then skyrocketed by 57.03% to $120.2 million in 2022, then grew by 25.19% to $150.5 million in 2023, then rose by 17.32% to $176.6 million in 2024.